Affordable Access

np1: a computer program for dose escalation strategies in phase I clinical trials.

Authors
  • 1
Type
Published Article
Journal
Computer Methods and Programs in Biomedicine
0169-2607
Publisher
Elsevier
Publication Date
Volume
88
Issue
1
Pages
8–17
Identifiers
PMID: 17719124
Source
Medline

Abstract

The continual reassessment method is a recommended dose escalation design for including patients in phase I clinical trials designed to estimate the maximum tolerated dose. However, for a particular trial, the implementation of these methods requires extensive computer programming. Standard 3+3 designs do not require this, but have shown to possess poor statistical properties. np1 is a user friendly computer program which has implemented two continual reassessment methods for simulating and conducting a phase I clinical trial. Several options allow the user to investigate operating characteristics under various scenarios.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments